
Sign up to save your podcasts
Or


Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.
TPM E47 highlights >
Episode 47 links:
By Genialis4.7
77 ratings
Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is an AI-native biotech pioneering the use of generative chemogenomics and patient clinicogenomic data to virtually screen billions of potential drug candidates each day.
TPM E47 highlights >
Episode 47 links:

21,983 Listeners

229,070 Listeners

4,356 Listeners

112,751 Listeners

56,508 Listeners

10,272 Listeners

9,901 Listeners

5,472 Listeners

16,038 Listeners